What's Going On With Teladoc Health Stock After Earnings?
Portfolio Pulse from Erica Kollmann
Teladoc Health, Inc. (NYSE:TDOC) shares are trading lower after the company reported a second-quarter revenue miss and withdrew its full-year financial outlook. The stock hit a new 52-week low, with revenue down 2% year-over-year. The Integrated Care segment saw a 5% increase, but the BetterHealth segment fell 9%. Oppenheimer maintained an Outperform rating but lowered the price target from $21 to $17. The stock is down 7.95% at $8.68.
August 01, 2024 | 5:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Teladoc Health reported a Q2 revenue miss and withdrew its full-year financial outlook, causing shares to hit a new 52-week low. The stock is down 7.95% to $8.68. Oppenheimer maintained an Outperform rating but lowered the price target from $21 to $17.
The revenue miss and withdrawal of the financial outlook are significant negative factors. The stock hitting a new 52-week low and the lowered price target from Oppenheimer further indicate a negative short-term impact.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100